T2 Biosystems Inc.

OTC: TTOO · Real-Time Price · USD
0.13
0.01 (8.79%)
At close: Apr 04, 2025, 3:42 PM

T2 Biosystems Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
15.69M 10.33M 22.25M
Short-Term Investments
n/a n/a 10M
Long-Term Investments
n/a 1.65M 1.55M
Other Long-Term Assets
555K 43K 153K
Receivables
1.42M 2.16M 5.13M
Inventory
4.82M 4.35M 3.91M
Other Current Assets
3.26M 2.58M n/a
Total Current Assets
25.19M 19.42M 44.39M
Property-Plant & Equipment
9.05M 13.27M 14.44M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
9.61M 14.97M 16.14M
Total Assets
34.8M 34.39M 60.54M
Account Payables
1.53M 1.3M 2.83M
Deferred Revenue
224K 172K 518K
Short-Term Debt
41.28M 1.35M n/a
Other Current Liabilities
8.8M 3.03M n/a
Total Current Liabilities
56.15M 10.51M 11.69M
Long-Term Debt
n/a 49.65M 47.79M
Other Long-Term Liabilities
n/a 5.94M 4.58M
Total Long-Term Liabilities
6.68M 63.85M 61.75M
Total Liabilities
62.83M 74.36M 73.44M
Total Debt
49.5M 59.22M 57.15M
Book Value
n/a n/a n/a
Book Value Per Share
n/a n/a n/a
Common Stock
4K 8K 166K
Retained Earnings
-584.3M -534.53M -472.22M
Comprehensive Income
n/a n/a -4K
Shareholders Equity
-28.04M -39.97M -12.9M
Total Investments
651K 1.65M 10M